Implant Site Reaction
Conditions
Keywords
ISQ (implant stability quotient), inmediate loading, UVC, dental implants
Brief summary
Summary: Objective: The general objective is to compare the placement of standard implants with a surface photofunctionalization technique based on ultraviolet C radiation (UVC), having as working hypothesis that this photofunctionalization will accelerate the bone apposition on the implant surface and increase the amount of bone that binds to the implant, making it possible to load these photofunctionalized implants in less time. Design: Pilot, clinical, randomized, prospective, controlled, single-center, prospective study. Scope of the study: Master's Degree in Oral Surgery and Implantology. Faculty of Dentistry. Complutense University of Madrid. Subjects of the study: patients attending the Master's Degree in Oral Surgery and Implantology for rehabilitation with dental implants, regardless of the sector in which they have missing teeth. Key words: ISQ (implant stability quotient), inmediate loading, UVC, dental implants.
Interventions
RADIATIONUVC
It is proposed to evaluate and compare the ISQ at 1 week, 2 weeks, 3 weeks and 4 weeks in patients undergoing implant placement surgery by comparing photofunctionalised (study group) and non-photofunctionalised (control group) implants in both native bone and grafted bone. To assess whether immediate loading can be carried out before 4 weeks and how long the waiting time for implant loading can be reduced, by performing predictability curves.
Sponsors
Universidad Complutense de Madrid
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
blinding
Intervention model description
randomized clinical trial
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients over 18 years of age. * Patients requiring dental implant surgery with or without bone or soft tissue regeneration surgery. * Acceptance of the informed consent document.
Exclusion criteria
* Subjects with systemic diseases leading to untreated or uncontrolled haemostasis or coagulation disturbances. * Subjects with active infectious diseases (tuberculosis, HIV, syphilis, hepatitis, etc). * Patients under pharmacological treatment with monoclonal antibodies, bisphosphonates, chemotherapy or prolonged treatment with corticoids. * Patients with alcoholism or drug addiction. * Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bone regeneration | 3 months | Bone implant contact (BIC) Histotogic parameter in percentage |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| ISQ and marginal bone loss | 12 months | Implant stability quotient and marginal bone loss measure with X-rays (quantitative parameter) |
Countries
Spain
Contacts
Primary Contactjesus gd torres, PhD
Outcome results
None listed